nach oben

Erschienen in:

01.06.2019 | Case report

DTaP vaccine

Various toxicities: 6 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a prospective, observational, non-comparative multi-center post-marketing surveillance study involving 672 patients conducted between 9 June 2010 and 8 June 2016 at 10 hospitals in Korea (NCT01929291), 6 patients [ages and sexes not stated] were described, who developed diarrhoea (1 patient), fever (1 patient), chills (1 patient), fatigue (1 patient), rash (1 patient) and arthralgia (1 patient) following immunisation with a single dose of DTaP vaccine [Boostrix; Tdap; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis]. The prefilled syringe, which contained 0.5mL of DTaP sterile suspension, was administered as a single IM injection to the patients [times to reaction onsets and outcomes not stated]. …

Park HJ, et al. A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Korea. Journal of Korean Medical Science 34: e105, No. 12, Apr 2019. Available from: URL: http://doi.org/10.3346/jkms.2019.34.e105 - South Korea

Titel: DTaP vaccine
Various toxicities: 6 case reports
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63995-6

Springer Medizin

DTaP vaccine

Various toxicities: 6 case reports

Excerpt

Weitere Artikel der Ausgabe 1/2019

Infliximab

Docetaxel

Mycophenolate mofetil

Triamcinolone

Polyethylene-glycol

Nitrous oxide toxicity

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Infliximab

Docetaxel

Mycophenolate mofetil

Triamcinolone

Polyethylene-glycol

Nitrous oxide toxicity